Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity
May 12, 2024
![](http://cannabis.net/drive/1000/3743_8f0B_bigpharmaschedule3.jpg?width=200&height=200)
For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.